Literature DB >> 16442577

First evidence of pfcrt mutant Plasmodium falciparum in Madagascar.

Milijaona Randrianarivelojosia1, David A Fidock, Olivier Belmonte, Stephanie G Valderramos, Odile Mercereau-Puijalon, Frédéric Ariey.   

Abstract

The island of Madagascar, lying in the Indian Ocean approximately 250 miles from the African coast, has so far remained one of the few areas in the world without noticeable Plasmodium falciparum high-grade chloroquine (CQ) resistance. Here we report genotyping data on pfcrt in Madagascar. The pfcrt K76T mutation, which is critical for resistance to CQ, was detected in six (3.3%) of 183 P. falciparum isolates screened, within the mutant haplotypes CVIET and CVIDT. This is the first observation of pfcrt mutant parasites on the island. The current massive distribution of CQ for in-home management of fever in children will promote the dissemination of these mutant CQ-resistant parasites. In this context, genotyping of pfcrt remains a useful tool for CQ resistance surveillance as the prevalence of pfcrt mutations is far from saturation in Madagascar.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442577      PMCID: PMC2944659          DOI: 10.1016/j.trstmh.2005.10.009

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  15 in total

1.  Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay.

Authors:  Paul E Wilson; Walter Kazadi; Deborah Demster Kamwendo; Victor Mwapasa; Anne Purfield; Steven R Meshnick
Journal:  Acta Trop       Date:  2005-01       Impact factor: 3.112

Review 2.  Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance.

Authors:  Patrick G Bray; Rowena E Martin; Leann Tilley; Stephen A Ward; Kiaran Kirk; David A Fidock
Journal:  Mol Microbiol       Date:  2005-04       Impact factor: 3.501

3.  Sudden increase in number of isolates of Plasmodium falciparum resistant to chloroquine in Madagascar.

Authors:  J P Lepers; P Deloron; J C Mouden; J Le Bras; P Coulanges
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jul-Aug       Impact factor: 2.184

4.  [Drug resistance of Plasmodium falciparum along the borders of the highlands in Madagascar: outlook for a national control program].

Authors:  R Milijaona; L Raharimalala; L Ramambanirina; L H Ranaivo; R Jambou
Journal:  Med Trop (Mars)       Date:  1998

5.  In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.

Authors:  M Randrianarivelojosia; J L Sahondra Harisoa; L P Rabarijaona; L A Raharimalala; L Ranaivo; V Pietra; J B Duchemin; F Rakotomanana; V Robert; P Mauclere; F Ariey
Journal:  Parassitologia       Date:  2002-12

6.  Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests.

Authors:  M A Rason; F Ariey; L Rafidimanantsoa; B H Andrianantenaina; J L Sahondra Harisoa; M Randrianarivelojosia
Journal:  Parasite       Date:  2002-09       Impact factor: 3.000

7.  Plasmodium falciparum parasites in French Guiana: limited genetic diversity and high selfing rate.

Authors:  F Ariey; W Chalvet; D Hommel; C Peneau; A Hulin; O Mercereau-Puijalon; J B Duchemin; J L Sarthou; J M Reynes; T Fandeur
Journal:  Am J Trop Med Hyg       Date:  1999-12       Impact factor: 2.345

8.  Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros.

Authors:  M Randrianarivelojosia; R H Raherinjafy; R Migliani; O Mercereau-Puijalon; F Ariey; S A Bedja
Journal:  Parasite       Date:  2004-12       Impact factor: 3.000

9.  The Lys-76-Thr mutation in PfCRT and chloroquine resistance in Plasmodium falciparum isolates from Uganda.

Authors:  J Kyosiimire-Lugemwa; A J Nalunkuma-Kazibwe; G Mujuzi; H Mulindwa; A Talisuna; T G Egwang
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Jan-Feb       Impact factor: 2.184

10.  Monitoring susceptibility to sulfadoxine-pyrimethamine among cases of uncomplicated, Plasmodium falciparum malaria in Saharevo, Madagascar.

Authors:  L Randrianasolo; A Randriamanantena; L Ranarivelo; A Ratsimbasoa; O Domarle; M Randrianarivelojosia
Journal:  Ann Trop Med Parasitol       Date:  2004-09
View more
  10 in total

1.  Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.

Authors:  Valérie Andriantsoanirina; Didier Ménard; Stéphane Rabearimanana; Véronique Hubert; Christiane Bouchier; Magali Tichit; Jacques Le Bras; Rémy Durand
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

2.  Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).

Authors:  Paul S Callaghan; Matthew R Hassett; Paul D Roepe
Journal:  Biochemistry       Date:  2015-08-06       Impact factor: 3.162

3.  Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.

Authors:  Valérie Andriantsoanirina; Arsène Ratsimbasoa; Christiane Bouchier; Magali Tichit; Martial Jahevitra; Stéphane Rabearimanana; Rogelin Raherinjafy; Odile Mercereau-Puijalon; Rémy Durand; Didier Ménard
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

4.  Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.

Authors:  Valérie Andriantsoanirina; Arsène Ratsimbasoa; Christiane Bouchier; Martial Jahevitra; Stéphane Rabearimanana; Rogelin Radrianjafy; Voahangy Andrianaranjaka; Tantely Randriantsoa; Marie Ange Rason; Magali Tichit; Léon Paul Rabarijaona; Odile Mercereau-Puijalon; Rémy Durand; Didier Ménard
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

5.  Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt.

Authors:  Nobuyuki Takahashi; Kazuyuki Tanabe; Takahiro Tsukahara; Mawuli Dzodzomenyo; Lek Dysoley; Boualam Khamlome; Jetsumon Sattabongkot; Masatoshi Nakamura; Miki Sakurai; Jun Kobayashi; Akira Kaneko; Hiroyoshi Endo; Francis Hombhanje; Takafumi Tsuboi; Toshihiro Mita
Journal:  Malar J       Date:  2012-03-28       Impact factor: 2.979

6.  Drug-resistant malaria parasites introduced into Madagascar from Comoros Islands.

Authors:  Didier Ménard; Armand Eugène Randrianarivo-Solofoniaina; Bedja Said Ahmed; Martial Jahevitra; Valérie Andriantsoanirina; Justin Ranjalahy Rasolofomanana; Léon Paul Rabarijaona
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

7.  Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children.

Authors:  Arsène Ratsimbasoa; Milijaona Randrianarivelojosia; Pascal Millet; Jean Louis Soarès; Leon Rabarijaona; Benjamin Rakotoson; Denis Malvy; Didier Ménard
Journal:  Malar J       Date:  2006-09-14       Impact factor: 2.979

Review 8.  Genetics of chloroquine-resistant malaria: a haplotypic view.

Authors:  Gauri Awasthi; Aparup Das
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

9.  [Pcr-rflp genotyping of pfcrt and pfmdr1 in plasmodium falciparum isolates from children in Vatomandry, Madagascar].

Authors:  Élisabeth Ravaoarisoa; Voahangy Hanitriniaina Isabelle Andrianaranjaka; Aina David Ramanantsahala; Tovonahary Angelo Rakotomanga; Fanomezantsoa Ralinoro; Rianasoambolanoro Rakotosaona; Ranjàna Hanitra Randrianarivo; Danielle Aurore Doll Rakoto; Victor Jeannoda; Arsène Ratsimbasoa
Journal:  Med Trop Sante Int       Date:  2022-06-16

10.  Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar.

Authors:  Jonathan J Juliano; Milijaona Randrianarivelojosia; Benjamin Ramarosandratana; Frédéric Ariey; Victor Mwapasa; Steven R Meshnick
Journal:  Malar J       Date:  2009-03-16       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.